LYEL position history
The shares of Lyell Immunopharma (LYEL) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 79,097 shares, $1.6M, 0.21% of portfolio, New
- 2026 Q2: 344,025 shares, $4.8M, 0.44% of portfolio, Add +334.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|